A detailed history of Lebenthal Global Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 2,994 shares of JNJ stock, worth $465,567. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,994
Previous 3,234 7.42%
Holding current value
$465,567
Previous $472,000 2.75%
% of portfolio
0.1%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$145.48 - $167.38 $34,915 - $40,171
-240 Reduced 7.42%
2,994 $485,000
Q2 2024

Jul 24, 2024

BUY
$144.38 - $157.78 $133,984 - $146,419
928 Added 40.24%
3,234 $472,000
Q1 2024

May 09, 2024

SELL
$155.22 - $162.74 $6,208 - $6,509
-40 Reduced 1.71%
2,306 $364,000
Q3 2023

Nov 08, 2023

SELL
$155.75 - $174.48 $30,371 - $34,023
-195 Reduced 7.67%
2,346 $365,000
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $10,804 - $11,627
70 Added 2.83%
2,541 $420,000
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $6,193 - $7,390
-41 Reduced 1.63%
2,471 $383,000
Q4 2022

Feb 06, 2023

BUY
$160.2 - $179.79 $38,448 - $43,149
240 Added 10.56%
2,512 $443,000
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $16,819 - $18,601
-100 Reduced 4.22%
2,272 $403,000
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $282,279 - $320,568
-1,785 Reduced 42.94%
2,372 $420,000
Q4 2021

Apr 15, 2022

BUY
$155.93 - $173.01 $271,006 - $300,691
1,738 Added 71.85%
4,157 $710,000
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $12,112 - $13,460
75 Added 3.2%
2,419 $390,000
Q2 2021

Aug 05, 2021

SELL
$159.48 - $171.07 $506,827 - $543,660
-3,178 Reduced 57.55%
2,344 $386,000
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $315,018 - $350,847
2,058 Added 59.41%
5,522 $907,000
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $474,949 - $545,164
3,464 New
3,464 $545,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Lebenthal Global Advisors, LLC Portfolio

Follow Lebenthal Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.